Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-13-000011)

Filing Details

Accession Number:: 0000711377-13-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-18 18:28:06
Reporting Period:: 2013-04-16

Filing Date:: 2013-04-18
Accepted Time:: 2013-04-18 17:28:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188979	C Jack Parnell			Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-04-16	1,000	$51.11	10,073	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Common Stock (Right to Buy)	$0.00			14,000	14,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	14,000	14,000	Direct

Footnotes

Options were granted between 10/11/2007 and 10/4/2012, have 3 year vesting and 10 year lives with exercise prices between $16.53 and $43.00